Marshall S. Stanton is SVP, Clinical & MD Affair of ARTIVION, INC.. Currently has a direct ownership of 44,753 shares of AORT, which is worth approximately $2.05 Million. The most recent transaction as insider was on Feb 23, 2023, when has been sold 11,210 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 44.8K
30.29% 3M change
46.27% 12M change
Total Value Held $2.05 Million

Marshall S. Stanton Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 23 2023
BUY
Grant, award, or other acquisition
-
11,210 Added 18.17%
50,482 Common Stock
Nov 08 2022
BUY
Grant, award, or other acquisition
-
19,447 Added 33.16%
39,195 Common Stock
Feb 23 2022
BUY
Grant, award, or other acquisition
-
8,406 Added 29.86%
19,748 Common Stock
Feb 17 2022
SELL
Payment of exercise price or tax liability
$13,510 $17.5 p/Share
772 Reduced 6.37%
11,342 Common Stock
Feb 17 2022
BUY
Grant, award, or other acquisition
-
2,603 Added 17.69%
12,114 Common Stock
Mar 16 2021
BUY
Grant, award, or other acquisition
-
8,511 Added 47.23%
9,511 Common Stock
MSS

Marshall S. Stanton

SVP, Clinical & MD Affair
Kennesaw, GA

Track Institutional and Insider Activities on AORT

Follow ARTIVION, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AORT shares.

Notify only if

Insider Trading

Get notified when an Artivion, Inc. insider buys or sells AORT shares.

Notify only if

News

Receive news related to ARTIVION, INC.

Track Activities on AORT